Pharma Roundup: Change Looms at Sanofi, Children Highly Medicated, and More

Winds of change coming to Sanofi in 2009 -- In December, Chris Viehbacher will take the helm as CEO, and analysts are predicting he will bring sweeping changes (perhaps acquisitions or executive shake-ups) with him. [Source: FiercePharma]

U.S. children taking more drugs than ever before -- Especially prevalent treatments include those for hypertension, high cholesterol, and diabetes. Between 2002 and 2005, use of diabetes drugs alone doubled among children aged 5 to 19. [Source: Pharmalot]

Another state sues Lilly over Zyprexa -- This time, it's Minnesota. [Source: MSN Money]

Supreme Court hears Wyeth v. Levine arguments -- The Drug and Device Law blog has extremely thorough coverage of the case, whose impact on pharma companies should be substantial. The WSJ Health Blog summarizes the day's courtroom action.